Sai Life Sciences Limited
Invesco Mutual Fund increased its stake in Sai Life Sciences from 7.27% to 7.44% by purchasing 390,619 shares. The additional shares are valued at ₹55.56 crore, based on the current share price of ₹1422.20.
A contract research and manufacturing organization serving the pharmaceutical and biotechnology industries, Sai Life Sciences conducts research activities and produces customized solutions for clients globally. Incorporated in 1999, the company operates as a specialized service provider, offering integrated capabilities across drug development, formulation, and manufacturing to support its customers' product pipelines and commercial operations in India and international markets.
Indian subsidiary of Invesco Ltd, a US-listed global investment manager with over USD 1.8 trillion in AUM worldwide. Manages over Rs 1.2 lakh crore in India. Known for its Invesco India Contra Fund, which runs a contrarian, undervalued stock strategy against consensus market positioning. One of the few global AMC franchises maintaining a strong active equity presence in India.